tiprankstipranks
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
US Market

TransMedics Group (TMDX) Income Statement

Compare
1,348 Followers

TransMedics Group Income Statement

Last quarter (Q4 2024), TransMedics Group's total revenue was $121.62M, an increase of 49.83% from the same quarter last year. In Q4, TransMedics Group's net income was $6.86M. See TransMedics Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 441.54M$ 241.62M$ 93.46M$ 30.26M$ 25.64M
Gross Profit
$ 262.08M$ 154.09M$ 65.27M$ 21.16M$ 16.64M
Operating Expenses
$ 224.59M$ 182.82M$ 96.71M$ 60.59M$ 43.02M
Depreciation and Amortization
$ 19.76M$ 8.18M$ 4.20M$ 2.65M$ 1.58M
EBITDA
$ 69.95M$ -7.60M$ -28.96M$ -38.49M$ -23.15M
Operating Income
$ 37.50M$ -28.73M$ -31.44M$ -39.43M$ -26.38M
Other Income/Expenses
$ -1.72M$ 2.06M$ -4.73M$ -4.75M$ -2.33M
Pretax Income
$ 35.78M$ -26.67M$ -36.16M$ -44.18M$ -28.72M
Net Income
$ 35.46M$ -25.03M$ -36.23M$ -44.22M$ -28.75M
Per Share Metrics
Basic EPS
$ 1.07$ -0.77$ -1.23$ -1.60$ -1.16
Diluted EPS
$ 1.01$ -0.77$ -1.23$ -1.60$ -1.16
Weighted Average Shares Outstanding
33.23M 32.52M 29.56M 27.62M 24.70M
Weighted Average Shares Outstanding (Diluted)
35.22M 32.52M 29.56M 27.62M 24.70M
Currency in USD

TransMedics Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis